Sara R. Simon


Morristown, NJ | New York, NY
Share with:


Sara R. Simon is an associate of Porzio, Bromberg & Newman, P.C. and a member of the firm's Life Sciences Compliance and Regulatory Counseling Department. She is also a Compliance Associate with the firm’s subsidiary, Porzio Life Sciences, LLC.

Sara counsels pharmaceutical, medical device and biotechnology companies on a variety of compliance-related issues, including federal and state fraud and abuse laws, FDA promotional regulations, transparency and aggregate spend, and industry standards regarding interactions with healthcare professionals. As a Compliance Associate with Porzio Life Sciences, Sara also assists in the creation, development, and implementation of the subsidiary’s products and services.

Sara provides regulatory healthcare compliance advice regarding federal and state anti-kickback and anti-referral laws and is fluent in organizational HIPAA policies and procedures. She also has structured varied business arrangements between health care providers, focusing on structuring healthcare practices, and counseling clients regarding compliance with state and federal health care laws and regulatory issues.

To further advance her knowledge in the life sciences industry, Sara has also completed the Seton Hall Law US Healthcare Compliance Certification Program, where she also served as Director. 

Speaking Engagements

  • "State of the Industry – A Closer Look at the Drug Pricing Transparency Landscape," Drug Pricing Transparency Congress, Philadelphia, PA, 3/29/2022
  • "Anticipating Reporting Responsibilities and Making Sure Your Company is Prepared," Porzio Life Sciences Webinar, 9/15/2021
  • International Pharma Congress Mini Summit 21: Global Price Transparent Reporting  , 6/15/2021
  • Porzio Life Sciences Webinar - 2021 Life Sciences Compliance Outlook, 3/16/2021
  • "2021 Life Sciences Compliance Outlook," Porzio Life Sciences, Webinar, 3/16/2021
  • "State of the Industry – Drug Pricing Transparency Landscape," 3rd Annual Pharma Pricing, Reimbursement & Market Access, 12/02/2020
  • "State of the Industry – Drug Pricing Transparency Landscape Address," 6th Edition Drug Pricing Transparency, 11/16/2020
  • "State of the Industry – Drug Pricing Transparency Landscape Address," 6th Edition Drug Pricing Transparency, 11/16/2020